Catsalyze, scaffolding technology
← Applications
Application 03

Diagnostics

Most sensitivity gains in an immunoassay are bought with new instruments, new consumables and a new validation campaign. We work one layer lower, on the conjugate itself, so the assay, the analyser and the workflow stay where they are.

Decameric ring displaying ten VHH binders in green and ten signal molecules in yellow
The object

Binder and reporter, on one ring

The PRX scaffold
Ten identical subunits, produced by fermentation, self-assemble inside the cells into a 13 nm ring (~300 kDa) with two display positions each. One object carrying both functions, small enough not to disturb the assay.
Ten binder copies
On the faces, giving avidity: several contacts hold a target a single binder would release.
Ten reporter copies
Around the rim, away from the binding sites: one binding event brings in ten reporters.
Genetic linkers
A library of genetic linkers is available. We select the best fit for your cargo: the right distance and flexibility.
Cargo-display strategies
Three strategies: genetic fusion, adapter–ligand binding, and chemical cross-linking. The optimal one is selected based on cargo properties, specificities, and the requirements of the target diagnostic application.

Where current approaches fall short

01
Limited signal per target

Conventional diagnostic reagents may provide limited signal amplification per target-binding event, particularly when only a few reporter molecules are associated with each binder.Impact: reduced sensitivity and limited detection of low-abundance targets.

02
Uncontrolled molecular organization

Conventional conjugation approaches can offer limited control over the number, spacing, and relative positioning of binders and reporters.Impact: variable binding performance, signal output, and assay reproducibility.

03
Complex reagent optimization

Combining target recognition and signal generation often requires extensive optimisation of component ratios, coupling conditions, and reagent formulation.Impact: longer development cycles, batch variability, and increased manufacturing complexity.

04
The cost of switching

A more sensitive platform means new hardware in every lab. A better reagent means a new lot number.

What the scaffold changes

The PRX ring provides a modular architecture for co-displaying binders and reporter molecules on a single scaffold. Its distinct display positions allow the two functions to be organised separately, with component loading and attachment strategies adapted to the requirements of each diagnostic application.

Avidity

Display multiple binders on one scaffold to promote avidity and target retention.

Enhanced signal potential

Co-localise multiple reporters with the target-binding component to increase the signal generated per captured target, depending on the reporter system.

Organized by design

Define component number, composition, and spatial arrangement through the scaffold architecture and the selected display strategy.

Flexible reagent engineering

Combine genetic fusion, adapter–ligand binding, or chemical cross-linking to accommodate different binders, reporters, and assay requirements.

Designed for existing diagnostic workflows

Develop new reagent formats with the potential to improve assay performance while retaining existing instrumentation and protocols, where compatibility permits.

From Conventional Conjugates to Multivalent Diagnostic Reagents

Sandwich assay: a single labelled detection binder on the left, the ring carrying binders and signal molecules on the right
Conventional conjugate

One binder, one reporter: limited signal generated per binding event.

Scaffolded conjugate

Multiple binders support multivalent target capture, while multiple reporters increase signal potential per binding event. One sharper reagent.

Formats covered

ELISA

Replace the conventional detection conjugate, or scaffold both capture and detection reagents to explore further performance gains.

Immuno-PCR

Display a defined number of DNA reporters per binding event to support controlled signal amplification.

Flow cytometry

Develop higher-signal reagents for low-abundance targets, designed for use with existing instruments.

Lateral flow

Increase signal intensity at the test line while retaining the existing strip architecture, subject to assay compatibility.

How we start

A 12-week feasibility on a single analyte

One analyte, one design iteration, and a head-to-head benchmark against your current conjugate, with acceptance criteria defined upfront. Success means improved analytical performance while maintaining blank performance: not simply generating a stronger signal.

Scope your feasibility study

Published evidence

Independent studies from other research groups supporting the scientific principles of multivalency and reporter amplification in immunoassays. These publications provide external evidence for the underlying concepts

Enhancing the sensitivity of nanobodies through covalent and non-covalent polymerization
Wang et al., RSC Advances, 2026 · 10.1039/d5ra03619d

A 14-valent display built on a heptameric protein scaffold improved antigen capture more than tenfold in magnetic bead and ELISA formats, the closest published analogue to our approach.

Design of luciferase-displaying protein nanoparticles for use as highly sensitive immunoassay detection probes
Yusuke Ikeda, Yasumasa Mashimo, Masayasu Mie, Eiry Kobatake; Analyst 2016; 141 (24): 6557–6563.

Demonstrates how protein scaffolds displaying multiple reporter enzymes can enhance assay sensitivity. Multivalent NanoLuc display increased ELISA detection sensitivity by approximately 10-fold compared with the monomeric reporter, highlighting the potential of scaffold-based signal amplification in diagnostics.

Stuck on a diagnostic project? Bring it to us.

We assess, under NDA, whether probe or ligand scaffolding can fix what is holding your project. If it is not the lever you need, we will tell you plainly.

Let's talk
Confidential. No commitment.